Reuters logo
BRIEF-Ovid Therapeutics Q3 loss per share $0.38
2017年11月9日 / 晚上10点03分 / 8 天前

BRIEF-Ovid Therapeutics Q3 loss per share $0.38

Nov 9 (Reuters) - Ovid Therapeutics Inc:

* Ovid Therapeutics reports third quarter 2017 financial results and corporate progress

* Q3 loss per share $0.38

* Q3 earnings per share view $-0.54 -- Thomson Reuters I/B/E/S

* Ovid Therapeutics Inc - ‍cash and cash equivalents $96 million as at Sept 30 , 2017 versus $51.9 million as at Dec 31, 2016​ Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below